Table A2.

Multiple reaction monitoring (MRM) transitions, MS conditions and retention (RT) times of the determined mycotoxins.

Mycotoxin	RT (min)	Precursor (m/z)	Products (m/z)	Q1 Pre Bias (V)	CE	Q3 Pre Bias (V)
15-ADON	6.54	355.9	260.9	−2	−16	−30
			136.9	−26	−20	−22
3−ADON	6.589	338.9	231	−24	−15	−22
			213	−12	−17	−20
HT−2	8.817	425	263	−20	−12	−18
			104.9	−16	−47	−19
AFG2	7.507	331	245.1	−12	−32	−24
			313	−12	−24	−20
AFG1	7.767	329	243	−12	−28	−23
			311.1	−16	−24	−14
AFB1	8.25	313	241	−22	−41	−23
			285.1	−22	−24	−29
FB3	8.754	706.3	336.3	−40	−39	−11
			354.4	−20	−35	−24
FB2	8.95	706.1	336.3	−20	−38	−22
			318.3	−26	−41	−22
β−ZEL	8.949	323.1	277.2	−16	−16	−18
			305.2	−16	−11	−20
α−ZEL	9.415	323.1	277.2	−17	−17	−18
			305.2	−24	−9	−20
T−2	9.674	467.2	245.1	−13	−11	−16
			305.2	−22	−11	−20
ZEN	10.063	319.1	185	−12	−27	−30
			187.1	−15	−21	−19
AME	10.125	273	128.1	−10	−49	−21
			115.1	−18	−54	−19
DON	3.874	297.1	231	−21	−13	−26
			249.1	−14	−12	−25
			221	−12	−38	−21
FB1	7.97	722.2	352.2	−34	−42	−11
			334.3	−20	−42	−11
AFB2	8.007	315	259.1	−22	−31	−25
			287	−23	−26	−30

3-ADON: 3-Acetyldeoxynivalenol, 15-ADON: 15-Acetyldeoxynivalenol, DON: Deoxynivalenol, α-ZEL: α-Zearalenol, ZEN: Zearalenone, β-ZEL: β-Zearalenol, FB₁: Fumonisin B₁, FB₂: Fumonisin B₂, FB₃: Fumonisin FB₃, T-2: T-2 toxin, HT-2: HT-2 toxin, AFB₁: Aflatoxins B₁, AFB₂: Aflatoxin B₂, AFG₁: Aflatoxin G₁ and AFG₂: Aflatoxin G₂, and AME: Alternariol monomethyl ether.